CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Operating expenses:
Selling, general and administrative	$ 3,321	$ 4,946	$ 7,970	$ 8,787
Research and development	4,439	9,025	10,172	18,230
Change in fair value of contingent consideration	(161,233)		(97,464)
Total operating costs and expenses	(153,473)	13,971	(79,322)	27,017
Income (loss) from operations	153,473	(13,971)	79,322	(27,017)
Other income (loss):
Change in fair value of convertible notes	1,795	(1,453)	1,708	(6,110)
Change in fair value of warrants	5,905		(14,999)
Loss on embedded forward purchase agreements and derivative liabilities, net	2,905		(20,012)
Other income, net	34	45	75	109
Total other income (loss), net	10,639	(1,408)	(33,228)	(6,001)
Income (loss) before taxes	164,112	(15,379)	46,094	(33,018)
Net income (loss) and comprehensive income (loss)	$ 164,112	$ (15,379)	$ 46,094	$ (33,018)
Basic net income (loss) per share (in dollars per share)	$ 4.22	$ (0.11)	$ 1.21	$ (0.24)
Diluted net income (loss) per share (in dollars per share)	$ 4.22	$ (0.11)	$ 1.21	$ (0.24)
Weighted average shares of common stock outstanding used to compute basic net income (loss) per share	38,843,627	138,825,356	38,055,850	138,825,356
Weighted average shares of common stock outstanding used to compute diluted net income (loss) per share	38,843,627	138,825,356	38,055,850	138,825,356
Financial Designation, Predecessor and Successor [Fixed List]	Successor	Predecessor	Successor	Predecessor